Available as part of the Tidelift Subscription. The maintainers of org.mockito:mockito-core and thousands of other packages are working with Tidelift to deliver commercial support and maintenance for ...
Suggested remit: To appraise the clinical and cost effectiveness of givinostat within its marketing authorisation for treating Duchenne muscular dystrophy in people 6 years and over. Anticipate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback